Table 4 Spearman’s correlation coefficients between 6-month changes in right ventricular indices, biomarkers and blood pressure
Biomarker | Empagliflozin 10 mg (n = 44)* | Placebo (n = 46)* | ||||||
|---|---|---|---|---|---|---|---|---|
RVEDVI | RVESVI | RVMI | RVEF | RVEDVI | RVESVI | RVMI | RVEF | |
NT-pro-BNP, pg/mL | 0.04 | − 0.06 | 0.06 | 0.11 | − 0.05 | − 0.18 | 0.06 | 0.15 |
High sensitivity troponin I, ng/mL | 0.19 | 0.26 | 0.17 | − 0.16 | − 0.02 | − 0.15 | 0.07 | 0.26 |
Systolic blood pressure | 0.03 | 0.06 | 0.04 | 0.03 | 0.15 | 0.26 | − 0.02 | − 0.21 |
Diastolic blood pressure | − 0.10 | − 0.09 | 0.01 | 0.06 | 0.06 | 0.13 | 0.12 | − 0.19 |